CClassifation of CannabisPublic classificationby Justin Strekal, NORML Political Director
October 16, 2018
Comments
The US Food and Drug Administration is seeking public comments specific to whether changes ought to be recommended regarding the international classification of cannabis as a controlled substance. Members of the public have until October 31, 2018 to submit their comments to the FDA for consideration.
The FDA says that the comments “will be considered in preparing a response from the United States to the World Health Organization regarding the abuse liability and diversion” of marijuana and certain other substances.
In April, in response to a similar FDA request, NORML collected and hand-delivered over 10,000 comments to the agency calling on it to recommend a lifting of international restrictions criminalizing the plant. In total, comments from NORML members totaled over 60% of the public comments submitted nationwide.
Click here to submit a public comment NOW
In NORML’s latest comments to the FDA, it opined that “cannabis be removed from the international drug conventions so that nations that wish to do so may further expand their regulations governing cannabis’ use, possession, production, and dispensing for either recreational or medical use.”
Let’s continue to dominate the debate. Click here to submit your own public comment now.
Then take the next step:
Share our Action Alert on Twitter
Share our Action Alert on Facebook
Posted in : ACTIVISM, Advocacy, Citizen Lobbyists, GOVERNMENT, Policy
Add Your Comment
Do your part to
help legalize marijuana! (how?)
Act!
Donate
Lawyers
Shop
NORML Newsletter
FDA Seeks Public Comments Regarding International Classification Of...
October 17, 2018
CClassifation of CannabisPublic classificationby Justin Strekal, NORML Political Director
October 16, 2018
Comments
The US Food and Drug Administration is seeking public comments specific to whether changes ought to be recommended regarding the international classification of cannabis as a controlled substance. Members of the public have until October 31, 2018 to submit their comments to the FDA for consideration.
The FDA says that the comments “will be considered in preparing a response from the United States to the World Health Organization regarding the abuse liability and diversion” of marijuana and certain other substances.
In April, in response to a similar FDA request, NORML collected and hand-delivered over 10,000 comments to the agency calling on it to recommend a lifting of international restrictions criminalizing the plant. In total, comments from NORML members totaled over 60% of the public comments submitted nationwide.
Click here to submit a public comment NOW
In NORML’s latest comments to the FDA, it opined that “cannabis be removed from the international drug conventions so that nations that wish to do so may further expand their regulations governing cannabis’ use, possession, production, and dispensing for either recreational or medical use.”
Let’s continue to dominate the debate. Click here to submit your own public comment now.
Then take the next step:
Share our Action Alert on Twitter
Share our Action Alert on Facebook
Posted in : ACTIVISM, Advocacy, Citizen Lobbyists, GOVERNMENT, Policy
Add Your Comment
Do your part to
help legalize marijuana! (how?)
Act!
Donate
Lawyers
Shop
NORML Newsletter
Search
RECENT PRESS RELEASES
UBS cuts Fortinet stock price target on mixed...
SWI Editorial StaffMay 3, 2024|
Earnings call: Coinbase Q1 2024 results show substantial...
SWI Editorial StaffMay 3, 2024|
Earnings call: Clearfield surpasses Q2 sales expectations, plans...
SWI Editorial StaffMay 3, 2024|
JPMorgan taps ChatGPT for new thematic investment suite
SWI Editorial StaffMay 3, 2024|
AI a growing tool for those interested in...
SWI Editorial StaffMay 3, 2024|
Earthrise Energy to award $22,200 in grants to...
SWI Editorial StaffMay 3, 2024|
Related Post
Coinbase Delivers Major Earnings, Revenue Beat Thanks To...
US stock futures bounce on Apple boost; Nonfarm...
Jack Dorsey’s Block says it will buy bitcoin...
Play Apple Stock Like Warren Buffett, Advises Bernstein